Cargando…

1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States

BACKGROUND: Pre-exposure prophylaxis (PrEP) is used to prevent HIV acquisition and is up to 99% effective when users are fully adherent. Research has shown an inverse relationship between mental health difficulties and PrEP adherence. This analysis aims to understand the real-world impact of mental...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennessy, Fritha, Turner, Libby, Higgins, Victoria, Piercy, James, Holbrook, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677574/
http://dx.doi.org/10.1093/ofid/ofad500.1374
_version_ 1785150162003296256
author Hennessy, Fritha
Turner, Libby
Higgins, Victoria
Piercy, James
Holbrook, Tim
author_facet Hennessy, Fritha
Turner, Libby
Higgins, Victoria
Piercy, James
Holbrook, Tim
author_sort Hennessy, Fritha
collection PubMed
description BACKGROUND: Pre-exposure prophylaxis (PrEP) is used to prevent HIV acquisition and is up to 99% effective when users are fully adherent. Research has shown an inverse relationship between mental health difficulties and PrEP adherence. This analysis aims to understand the real-world impact of mental health on PrEP adherence in the United States (US). METHODS: Data were drawn from the Adelphi PrEP Disease Specific Programme™, a real-world, study with retrospective clinical data and cross-sectional PROs conducted August 2021-March 2022 in the US. Physicians provided data on patient demographics, satisfaction, components of mental health including anxiety/depression and PrEP adherence. Current PrEP users (PU) provided data on satisfaction and adherence via the Adelphi Adherence Questionnaire (ADAQ), scored from 0 to 4 where lower scores indicate greater adherence. Analyses of variance and descriptive analyses were performed. RESULTS: PU (n=196) were categorized as having no (nMH, n=108), mild (mMH, n=44), or moderate/severe mental health problems (sMH, n=26). Anxiety (38.6% mMH, 32.3% sMH) and depression (25.0% mMH, 61.5% sMH) were the most common mental health-related comorbidities (physician-stated). PU with sMH had significantly poorer patient-reported adherence than nMH (ADAQ mean [standard deviation] nMH, 0.29 [0.54]; mMH 0.64 [0.59]; sMH 0.78 [0.6]; p< 0.01). The most common reason for poor adherence was forgetting to take PrEP (27.3% nMH; 21.9% mMH; 50.0% sMH; physician stated). A higher percentage of PU with sMH were dissatisfied with the ease of use of their PrEP than PU with nMH (Fig 1A), a lower percentage of PU with sMH felt PrEP was easy to access than PU with nMH (Fig 1B). PU stated drivers of poor adherence included forgetfulness, not being in usual routine, stigma (Fig 2), particularly in PU with sMH. [Figure: see text] [Figure: see text] CONCLUSION: Poorer mental health was associated with lower PrEP adherence, and was a barrier to effective use. Reasons for poor adherence are multi-factorial and not just related to forgetting to take PrEP. Development of PrEP that is easier to use and easier to access will benefit all PrEP users, particularly for people identified as having poorer mental health. DISCLOSURES: James Piercy, MSc, Adelphi: Salaried Employee
format Online
Article
Text
id pubmed-10677574
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106775742023-11-27 1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States Hennessy, Fritha Turner, Libby Higgins, Victoria Piercy, James Holbrook, Tim Open Forum Infect Dis Abstract BACKGROUND: Pre-exposure prophylaxis (PrEP) is used to prevent HIV acquisition and is up to 99% effective when users are fully adherent. Research has shown an inverse relationship between mental health difficulties and PrEP adherence. This analysis aims to understand the real-world impact of mental health on PrEP adherence in the United States (US). METHODS: Data were drawn from the Adelphi PrEP Disease Specific Programme™, a real-world, study with retrospective clinical data and cross-sectional PROs conducted August 2021-March 2022 in the US. Physicians provided data on patient demographics, satisfaction, components of mental health including anxiety/depression and PrEP adherence. Current PrEP users (PU) provided data on satisfaction and adherence via the Adelphi Adherence Questionnaire (ADAQ), scored from 0 to 4 where lower scores indicate greater adherence. Analyses of variance and descriptive analyses were performed. RESULTS: PU (n=196) were categorized as having no (nMH, n=108), mild (mMH, n=44), or moderate/severe mental health problems (sMH, n=26). Anxiety (38.6% mMH, 32.3% sMH) and depression (25.0% mMH, 61.5% sMH) were the most common mental health-related comorbidities (physician-stated). PU with sMH had significantly poorer patient-reported adherence than nMH (ADAQ mean [standard deviation] nMH, 0.29 [0.54]; mMH 0.64 [0.59]; sMH 0.78 [0.6]; p< 0.01). The most common reason for poor adherence was forgetting to take PrEP (27.3% nMH; 21.9% mMH; 50.0% sMH; physician stated). A higher percentage of PU with sMH were dissatisfied with the ease of use of their PrEP than PU with nMH (Fig 1A), a lower percentage of PU with sMH felt PrEP was easy to access than PU with nMH (Fig 1B). PU stated drivers of poor adherence included forgetfulness, not being in usual routine, stigma (Fig 2), particularly in PU with sMH. [Figure: see text] [Figure: see text] CONCLUSION: Poorer mental health was associated with lower PrEP adherence, and was a barrier to effective use. Reasons for poor adherence are multi-factorial and not just related to forgetting to take PrEP. Development of PrEP that is easier to use and easier to access will benefit all PrEP users, particularly for people identified as having poorer mental health. DISCLOSURES: James Piercy, MSc, Adelphi: Salaried Employee Oxford University Press 2023-11-27 /pmc/articles/PMC10677574/ http://dx.doi.org/10.1093/ofid/ofad500.1374 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Hennessy, Fritha
Turner, Libby
Higgins, Victoria
Piercy, James
Holbrook, Tim
1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States
title 1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States
title_full 1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States
title_fullStr 1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States
title_full_unstemmed 1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States
title_short 1539. Presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the United States
title_sort 1539. presence of mental health concerns is associated with poor adherence in people taking pre-exposure prophylaxis in real-world clinical practice in the united states
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677574/
http://dx.doi.org/10.1093/ofid/ofad500.1374
work_keys_str_mv AT hennessyfritha 1539presenceofmentalhealthconcernsisassociatedwithpooradherenceinpeopletakingpreexposureprophylaxisinrealworldclinicalpracticeintheunitedstates
AT turnerlibby 1539presenceofmentalhealthconcernsisassociatedwithpooradherenceinpeopletakingpreexposureprophylaxisinrealworldclinicalpracticeintheunitedstates
AT higginsvictoria 1539presenceofmentalhealthconcernsisassociatedwithpooradherenceinpeopletakingpreexposureprophylaxisinrealworldclinicalpracticeintheunitedstates
AT piercyjames 1539presenceofmentalhealthconcernsisassociatedwithpooradherenceinpeopletakingpreexposureprophylaxisinrealworldclinicalpracticeintheunitedstates
AT holbrooktim 1539presenceofmentalhealthconcernsisassociatedwithpooradherenceinpeopletakingpreexposureprophylaxisinrealworldclinicalpracticeintheunitedstates